The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleus

Nicotine and Tobacco Research

Volumn 6, Issue 6, 2004, Pages 899-912

  Balfour, David J K ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; NICOTINE; NICOTINIC RECEPTOR; PSYCHOSTIMULANT AGENT; SB 277011 A; TOBACCO SMOKE; UNCLASSIFIED DRUG;

BRAIN FUNCTION; BRAIN NERVE CELL; CELL NUCLEUS; CLINICAL PROTOCOL; DEPRESSION; DISEASE CLASSIFICATION; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; HUMAN; HYPOTHESIS; NEUROBIOLOGY; NICOTINE REPLACEMENT THERAPY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RELAPSE; REVIEW; SENSITIZATION; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

CONDITIONING, CLASSICAL; DOPAMINE; DRUG ADMINISTRATION ROUTES; HUMANS; NEURONS; NICOTINE; NUCLEUS ACCUMBENS; PSYCHOLOGICAL THEORY; SMOKING CESSATION; SYNAPSES; TOBACCO USE DISORDER;

EID: 12344316075     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200412331324965     Document Type: Review

References (109)

1. Andreoli, M., Tessari, M., Pilla, M., Valerio, E., Hagan, J. J., & Heidbreder, C. A. (2003). Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology, 28, 1272-1280.
2. Balfour, D. J. K. (2003). The psychopharmacology of tobacco dependence. Journal of Clinical Psychiatry Monograph, 18, 12-21.
3. Balfour, D. J. K., Benwell, M. E. M., Birrell, C. E., Kelly, R. J., & Al-Aloul, M. (1998). Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacology, Biochemistry, and Behavior, 59, 1021-1030.
4. Balfour, D. J. K., Benwell, M. E. M., & Vale, A. L. (1990). Studies on the role of mesolimbic dopamine in behavioral responses to chronic nicotine. In F. Adlkofer & K. Thurau (Eds.), Effects of nicotine on biological systems (pp. 407-416). Basel: Birkhauser Verlag.
5. Balfour, D. J. K., Birrell, C. E., Moran, R. J., & Benwell, M. E. M. (1996). Effects of acute D-CPPene on mesoaccumbens dopamine responses to nicotine in the rat. European Journal of Pharmacology, 316, 153-156.
6. Balfour, D. J. K., & Fagerström, K. O. (1996). Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacology and Therapeutics, 72, 51-81.
7. Balfour, D. J. K., & Ridley, D. L. (2000). The effects of nicotine on neural pathways implicated in depression: A factor in nicotine addiction?. Pharmacology, Biochemistry, and Behavior, 66, 79-85.
8. Balfour, D. J. K., Wright, A. E., Benwell, M. E. M., & Birrell, C. E. (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behavioral and Brain Research, 113, 73-83.
9. Bassareo, V., & Di Chiara, G. (1999). Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens medial shell/core compartments. Neuroscience, 89, 637-641.
10. Benowitz, N. L. (1996). Pharmacology of nicotine: Addiction and therapeutics. Annual Review of Pharmacology and Toxicology, 36, 597-613.
11. Benowitz, N. L. (1999). Nicotine addiction. Primary Care, 26, 611-631.
12. Benowitz, N. L., Porchet, H., & Jacob, P. III. (1990). Pharmacokinetics, metabolism and pharmacodynamics of nicotine. In S. Wonnacott, M. A. H. Russell, & I. P. Stolerman (Eds.), Nicotine psychopharmacology: Molecular, cellular and behavioural aspects, (pp. 112-157) Oxford: Oxford University Press.
13. Benwell, M. E. M., & Balfour, D. J. K. (1985). Nicotine binding to brain tissue from drug-naïve and nicotine-treated rats. The Journal of Pharmacy and Pharmacology, 37, 405-409.
14. Benwell, M. E. M., & Balfour, D. J. K. (1992). The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. British Journal of Pharmacology, 105, 849-856.
15. Benwell, M. E. M., Balfour, D. J. K., & Birrell, C. E. (1995). Desensitisation of nicotine-induced dopamine responses during constant infusion with nicotine. British Journal of Pharmacology, 114 211-217.
16. Benwell, M. E. M., Holtom, P. E., Moran, R. J., & Balfour, D. J. K. (1996). Neurochemical and behavioural interactions between ibogaine and nicotine in the rat. British Journal of Pharmacology, 117, 743-749.
17. Birrell, C. E., & Balfour, D. J. K. (1998). The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine. Psychopharmacology, 140, 142-149.
18. Breslau, N., Kilber, M. M., & Andreski, P. (1993). Nicotine dependence and major depression. Archives of General Psychiatry, 50 31-35.
19. Cadoni, C., & Di Chiara, G. (2000). Differential changes in the accumbens medial shell and core dopamine in behavioural sensitization to nicotine. European Journal of Pharmacology, 387, R23-R25.
20. Cadoni, C., Solinas, M., & Di Chiara, G. (2000). Psychostimulant sensitization: Differential changes in accumbal medial shell and core dopamine. European Journal of Pharmacology, 388, 69-76.
21. Caggiula, A. R., Donny, E. C., Chaudhri, N., Perkins, K. A., Evans-Martin, F. F., & Sved, A. F. (2002). Importance of nonpharmacological factors in nicotine self-administration. Physiology & Behavior, 77, 683-687.
22. Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharaib, M. A., Hoffman, A., Perkins, K. A., & Sved, A. F. (2001). Cue dependency of nicotine self-administration and smoking. Pharmacology, Biochemistry, and Behavior, 70, 515-530.
23. Caine, S. B., & Koob, G. F. (1994). Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. The Journal of Experimental Analysis of Behavior, 61, 213-221.
24. Cervo, L., Carnovali, F., Stark, J. A., & Mennini, T. (2003). Cocaine-seeking behavior in response to drug-associated stimuli in rats: Involvement of D3 and D2 dopamine receptors. Neuropsychopharmacology, 28, 1150-1159.
25. Chergui, K., Charlety, P. J., Akaoka, H., Saunier, C. F., Brunet, J.-L., Buda, M., Svensson, T. H., & Chauvet, G. (1993). Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. The European Journal of Neuroscience, 5, 137-144.
26. Chiamulera, C., Borgo, C., Falchetto, S., Valerio, E., & Tessari, M. (1996). Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology, 127, 102-107.
27. Clarke, P. B. S., Fu, D. S., Jakubovic, A., & Fibiger, H. C. (1988). Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. Journal of Pharmacology and Experimental Therapeutics, 246, 701-708.
28. Corrigall, W. A., & Coen, K. M. (1989). Nicotine maintains robust self-administration in rats on a limited access schedule. Psychopharmacology, 99, 473-478.
29. Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research, 653, 278-284.
30. Corrigall, W. A., Franklin, K. J. B., Coen, K. M., & Clarke, P. B. S. (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology, 107, 285-289.
31. Covey, L. S., Glassman, A. H., & Stetner, F. (1998). Cigarette smoking and major depression. Journal of Addictive Diseases, 17, 35-46.
32. Crombag, H. S., Grimm, J. W., & Shaham, Y. (2002). Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology, 27, 1006-1015.
33. Dagher, A., Bleicher, C., Astin, J. A., Gunn, R. N., Clarke, P. B., & Cumming, P. (2001). Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse, 42, 48-53.
34. Dawe, S., Gerada, C., Russell, M. A. H., & Gray, J. A. (1995). Nicotine intake in smokers increase following a single dose of haloperidol. Psychopharmacology, 117, 110-115.
35. Di Chiara, G. (1999). Drug addiction as a dopamine-dependent associative learning disorder. European Journal of Pharmacology, 375 13-30.
36. Di Chiara, G. (2000a). Role of dopamine in the behavioural actions of nicotine related to addiction. European Journal of Pharmacology, 393, 295-314.
37. Di Chiara, G. (2000b). Behavioural pharmacology and neurobiology of nicotine reward and dependence. In C. Clementi, D. Fornasari & C. Gotti (Eds.), Handbook of Experimental Pharmacology, vol. 14 (pp. 603-750). Berlin: Springer.
38. Di Chiara, G. (2002). Nucleus accumbens medial shell and core dopamine: Differential role in behavior and addiction. Behavioural Brain Research, 137, 75-114.
39. Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of the United States of America, 85, 5274-5278.
40. Donny, E. C., Chaudhri, N., Caggiula, A. R., Evans-Martin, F. F., Booth, S., Gharib, M. A., Clements, L. A., & Sved, A. F. (2003). Operant responding for a visual reinforcer in rats is enhanced by non-contingent nicotine: Implications for nicotine self-administration and reinforcement. Psychopharmacology, 169, 68-76.
41. Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998). Dramatic decreases in brain reward function during nicotine withdrawal. Nature, 393, 76-79.
42. Everitt, B. J., Dickinson, A., & Robbins, T. W. (2001). The neuropsychological basis of addictive behaviour. Brain Research. Brain Research Reviews, 36, 129-138.
43. Fowler, J. S., Logan, J., Wang, G. J., & Volkow, N. D. (2003). Monoamine oxidase and cigarette smoking. Neurotoxicology, 24 75-82.
44. Fowler, J. S., Volkow, N. D., Wang, G. J., Pappas, N., Logan, J., Shea, C., Alexof, D., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., & Wolf, A. P. (1996). Brain monoamine oxidase A inhibition in cigarette smokers. Proceedings of the National Academy of Sciences of the United States of America, 93, 14065-10469.
45. Gonon, F. G. (1988). Nonlinear relationship between impulse flow and dopamine released by rats midbrain dopaminergic neurons2as studied by in vivo electrochemistry. Neuroscience, 24, 2419-2428.
46. Gourlay, S. G., & Benowitz, N. L. (1997). Arteriovenous differences in plasma concentrations of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray and intravenous nicotine. Clinical Pharmacology and Therapeutics, 62, 453-463.
47. Gross, J., & Stitzer, M. L. (1989). Nicotine replacement: Ten weeks of tobacco withdrawal symptoms. Psychopharmacology, 98, 334-341.
48. Hajnal, A., & Norgen, R. (2002). Repeated access to sucrose augments dopamine turnover in the nucleus accumbens. Neuroreport, 12 2213-2216.
49. Hall, J., Parkinson, J. A., Connor, T. M. F., Dickinson, A., & Everitt, B. J. (2001). Involvement of the central nucleus of the amygdala and nucleus accumbens core in mediating Pavlovian influences on instrumental behaviour. European Journal of Neuroscience, 13, 1984-1992.
50. Heidbreder, C. A., Hedou, G., & Feldon, J. (1999). Behavioral neurochemistry reveals a new functional dichotomy in the medial shell subregion of the nucleus accumbens. Progress in Clinical and Biological Research, 23, 99-132.
51. Heimer, L., Zahm, D. S., Churchill, L., Kalivas, P. W., & Wohltman, C. (1991). Specificity in the projection patterns of accumbal core and medial shell in the rat. Neuroscience, 41, 89-125.
52. Hemby, S. E., No, C., Koves, T. R., Smith, J. E., & Dworkin, S. I. (1997). Differences in extracellular dopamine concentration in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology, 133, 7-16.
53. Henningfield, J. E., & Fant, R. V. (1999). Tobacco use as a drug addiction: The scientific foundation. Nicotine & Tobacco Research, 1(Suppl. 2), S31-S35.
54. Imperato, A., Mulas, A., & Di Chiara, G. (1986). Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. European Journal of Pharmacology, 132, 337-338.
55. Ikemoto, S. (2003). Involvement of the olfactory tubercle in cocaine reward: Intracranial self-administration studies. The Journal of Neuroscience, 23, 9305-9311.
56. Ito, R., Dalley, J. W., Howes, S. R., Robbins, T. W., & Everitt, B. J. (2000). Dissociation in conditioned dopamine release in the nucleus accumbens core and medial shell in response to cocaine cues and during cocaine-seeking behaviour in rats. The Journal of Neuroscience, 20, 7489-7495.
57. Ito, R., Robbins, T. W., & Everitt, B. J. (2004). Differential control over cocaine-seeking behaviour by nucleus accumbens core and shell. Nature Neuroscience, 7, 389-397.
58. Iyaniwura, T. T., Wright, A. E., & Balfour, D. J. K. (2001). Evidence that mesoaccumbens dopamine and locomotor responses to nicotine in the rat are influenced by pre-treatment dose and strain. Psychopharmacology, 158, 73-79.
59. Jarvis, M. J. (1988). Nicotine replacement as a sole therapy or as adjunct. Progress in Clinical and Biological Research, 261, 145-162.
60. Jarvis, M. J. (1994). A profile of tobacco smoking. Addiction, 89, 1371-1376.
61. Jarvis, M. J. (1997). Patterns and predictors of unaided smoking cessation in the general population. In C. T. Bollinger, & K. O. Fagerström (Eds.), The tobacco epidemic (pp. 151-164). Basel: Karger.
62. Jorenby, D. (2002). Clinical efficacy of bupropion in the management of smoking cessation. Drugs, 62(Suppl. 2), 25-35.
63. Jung, M. E., Lal, H., & Gatch, M. B. (2002). The discriminative stimulus effects of pentyleneterazol as a model of anxiety: Recent developments. Neuroscience and Biobehavioral Reviews, 26, 429-439.
64. Kalivas, P. W., & McFarland, K. (2003). Brain circuitry and the reinstatement of cocaine-seeking behaviour. Psychopharmacology, 168, 44-56.
65. Kelley, A. E., & Berridge, K. C. (2002). The neuroscience of natural rewards: Relevance to addictive drugs. The Journal of Neuroscience, 22, 3306-3311.
66. Kenny, P. J., & Markou, A. (2001). Neurobiology of the nicotine withdrawal syndrome. Pharmacology, Biochemistry, and Behavior, 70, 531-549.
67. Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24 97-129.
68. Laviolette, S. R., Alexson, T. O., & van der Kooy, D. (2002). Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. The Journal of Neuroscience, 22, 8653-8660.
69. Laviolette, S. R., & van der Kooy, D. (2004). The neurobiology of nicotine addiction: Bridging the gap from molecules to behaviour. Nature Reviews. Neuroscience, 5, 55-65.
70. Laviolette, S. R., & van der kooy, D. (2003). The Motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha 7-subunit-containing nicotinic acetylcholine receptor. Psychopharmacology, 166, 306-313.
71. Louis, M., & Clarke, P. B. (1998). Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats. Neuropharmacology, 37, 1503-1513.
72. Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992). Rodent model of nicotine abstinence syndrome. Pharmacology, Biochemistry, and Behavior, 43, 779-784.
73. Markou, A., Kosten, T. R., & Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology, 18, 135-174.
74. Nirenberg, M. J., Chan, J., Pohorille, A., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1997). The dopamine transporter: Comparative ultrastructure of dopaminergic axons in the limbic and motor components of the nucleus accumbens. The Journal of Neuroscience, 17, 6899-6907.
75. Nisell, M., Nomikos, G. G., Hertel, P., Panagis, G., & Svensson, T. H. (1996). Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse, 22, 369-381.
76. Nissbrandt, H., Elverfors, A., & Engberg, G. (1994). Pharmacologically induced cessation of burst activity in nigral dopamine neurons: Significance for terminal dopamine efflux. Synapse, 17, 217-224.
77. Nomikos, G. G., Damsma, G., Wenkstern, D., & Fibiger, H. C. (1989). Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology, 2, 273-279.
78. Parkinson, J. A., Olmstead, M. C., Burns, L. H., Robbins, T. W., & Everitt, B. J. (1999). Dissociation in effects of lesions of the nucleus accumbens, core and shell on appetitive pavlovian approach behaviour and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. The Journal of Neuroscience, 19, 2401-2411.
79. Pettit, H. O., Ettenberg, A., Bloom, F. E., & Koob, G. F. (1984). Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology, 84, 167-173.
80. Pidoplichko, V., De Biasi, M., Williams, J. T., & Dani, J. (1997). Nicotine activates and desensitizes midbrain dopamine neurones. Nature, 390, 401-404.
81. Pontieri, F., Tanda, G., Orzi, F., & Di Chiara, G. (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature, 382, 255-257.
82. Ranaldi, R., Pocock, D., Zereik, R., & Wise, R. A. (1999). Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration. The Journal of Neuroscience, 19, 4102-4109.
83. Richmond, R., & Zwar, N. (2003). Review of bupropion for smoking cessation. Drug and Alcohol Review, 22, 203-220.
84. Roberts, D. C., & Koob, G. F. (1982). Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacology, Biochemistry, and Behavior, 17 901-904.
85. Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research. Brain Research Reviews, 18, 247-291.
86. Robinson, T. E., & Berridge, K. C. (2000). The psychology and neurobiology of addiction: An incentive-sensitization view. Addiction, 95(Suppl. 2), S91-S117.
87. Rocha, B. A., Fumagalli, F., Gainetdinov, R. R., Jones, S. R., Ator, R., Giros, B., Miller, G. W., & Caron, M. G. (1998). Cocaine self-administration in dopamine-transporter knockout mice. Nature Neuroscience, 1, 132-137.
88. Rodd-Henricks, Z. A., McKenzie, D. L., Ting-Kai, L., Murphy, J. M., & McBride, W. J. (2002). Cocaine is self-administered into the medial shell but not the core of the nucleus accumbens of Wistar rats. Journal of Pharmacology and Experimental Therapeutics, 303, 1216-1226.
89. Rose, J. E., Behm, F. M., & Levin, E. D. (1993). Role of nicotine dose and sensory cues in the regulation of smoke intake. Pharmacology, Biochemistry, and Behavior, 44, 891-900.
90. Rose, J. E., Behm, F. M., Westman, E. C., & Coleman, R. E. (1999). Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: Implication for addiction. Drug and Alcohol Dependence, 56, 99-107.
91. Rose, J. E., Behm, F. M., Westman, E. C., & Johnson, M. (2000), Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology, Biochemistry, and Behavior, 67, 71-81.
92. Schilström, B., Nomikos, G. G., Nisell, M., Hertel, P., & Svensson, T. H. (1998). N-methyl-D-aspartate receptor antagonisms in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience, 82, 781-789.
93. Sellings, L. H. L., & Clarke, P. B. S. (2003). Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial medial shell and core. The Journal of Neuroscience, 23, 6295-6303.
94. Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998). Antidepressant-like effects of chronic nicotine on learned helplessness paradigm in rats. Biological Psychiatry, 43, 389-391.
95. Shoaib, M., Benwell, M. E. M., Akbar, M. T., Stolerman, I. P., & Balfour, D. J. K. (1994). Behavioural and neurochemical adaptations to nicotine in rats: Influence of NMDA antagonists. British Journal of Pharmacology, 111, 1073-1080.
96. Shoaib, M., & Stolerman, I. P. (1999). Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats. Psychopharmacology, 143, 318-321.
97. Suemaru, K., Gomita, Y., Furunu, K., & Araki, Y. (1993). Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats. Pharmacology, Biochemistry, and Behavior, 46, 135-139.
98. Sokolowski, J. D., Conlan, A. N., & Salamone, J. D. (1998). A microdialysis study of nucleus accumbens core and medial shell dopamine during operant responding in the rat. Neuroscience, 86, 1001-1009.
99. Taylor, J. R., & Robbins, T. W. (1984). Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology, 84, 405-412.
100. Taylor, J. R., & Robbins, T. W. (1986). 6-Hydroxydopamine lesions of the nucleus accumbens, but not the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens D-amphetamine. Psychopharmacology, 90, 390-397.
101. Teneggi, V., Tiffany, S. T., Squassante, L., Milleri, S., Ziviani, L., & Bye, A. (2002). Smokers deprived of cigarettes for 72 h: Effect of nicotine patches on craving and withdrawal. Psychopharmacology, 164, 177-187.
102. Turner, D. M. (1975). Influence of route of administration on metabolism of [14C]nicotine in four species. Xenobiotica, 5, 553-561.
103. Vorel, S. R., Ashby, C. R., Paul, M., Liu, X., Hayes, R., Hagan, J. J., Middlemiss, D. N., Stemp, G., & Gardner, E. L. (2002). Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. The Journal of Neuroscience, 22 9595-9603.
104. West, R. J. (1988). Nicotine: A dependence-producing substance. Progress in Clinical and Biological Research, 261, 237-259.
105. West, R., & Shiffman, S. (2001). Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: A systematic review. Psychopharmacology, 155, 115-122.
106. Wise, R. A., & Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological Review, 94, 469-492.
107. Wolterink, G., Phillips, G. D., Cador, M., Donselaar-Wolterink, I., Robbins, T. W., & Everitt, B. J. (1993). Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement. Psychopharmacology, 110, 355-364.
108. Wyvell, C. L., & Berridge, K. C. (2000). Intra-accumbens amphetamine increases the pure incentive salience of a Pavlovian cue for food reward: Enhancement of "wanting" without either " liking" or reinforcement. The Journal of Neuroscience, 20, 8122-8130.
109. Zahm, D. S., & Brog, J. S. (1992). On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience, 50, 751-767.